Niagara Falls, NY – October 29, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac Positron Emission Tomography (“PET”) imaging, is pleased to announce today that the Company is now fully reporting and “Current” with the OTC Pink Markets.
This “Pink Current” status provides greater insight and transparency as to the Company’s structure and financial health. Achieving this Current status also removes the “stop or yield” sign associated with non-filing companies with OTC Markets. Positron plans to upgrade to the OTCQB as soon as it can meet all the requirements to trade on this market.
Adel Abdullah, President of Positron stated: "The Company has returned to being a fully reporting publicly traded security. We appreciate the loyalty, patience, and support from our shareholders during this period. Bringing the Company Pink Current has been a key focus for our management team during the course of 2021. This step is expected to increase shareholder value and allow us to continue focusing on driving market penetration and revenue expansion for Positron’s innovative PET product.”